texas

JT Global to join Aduna to advance secure CPaaS solutions with Network APIs

PLANO, Texas, June 19, 2025 /PRNewswire/ -- Aduna, the global aggregator of network APIs, today announced that JT Global, a leading…

6 months ago

Tech Mahindra and Wipro join Aduna to accelerate global adoption of network APIs

PLANO, Texas, June 18, 2025 /PRNewswire/ -- Aduna, the global aggregator of network APIs, today announced that leading global system…

6 months ago

Aduna collaborates with NTT DOCOMO to strengthen global network API ecosystem with Japan launch, enabling scalable innovation

PLANO, Texas, June 17, 2025 /PRNewswire/ -- Aduna, the global aggregator of network APIs, and NTT DOCOMO, Inc., one of…

6 months ago

AutoScheduler Receives 2025 Top Supply Chain Projects Award

AUSTIN, Texas, June 16, 2025 (GLOBE NEWSWIRE) -- AutoScheduler.AI, a leader in Agentic AI Warehouse Orchestration, has received the 2025…

6 months ago

XRP price: Massive sell-off forces holders to flock to EarnMining for stable income

Houston, Texas, June 16, 2025 (GLOBE NEWSWIRE) -- After experiencing a short-term price plunge, the XRP market has set off…

6 months ago

Ripplecoin Mining Free Cloud Mining App, High-yield Cloud Mining Investment Guide for BTC and XRP Holders

Free mobile cloud mining app, investors can easily mine on their mobile phones anytime and anywhere without hardware, and steadily…

6 months ago

SEON Launches AI-Powered Anti-Money Laundering Suite, Enhancing its Comprehensive Command Center for Risk Management

AUSTIN, Texas, June 10, 2025 (GLOBE NEWSWIRE) -- SEON, a global leader in digital fraud prevention, announced the launch of…

6 months ago

Alkegen Enters Full Production of EV Battery Fire Protection Aerogels

World's Largest Supplier of Cell Spacers Delivering OEMs a Full Portfolio of Advanced Thermal Solutions IRVING, Texas, June 4, 2025…

7 months ago

Actuate Therapeutics Presents Topline Elraglusib Phase 2 Data at ASCO 2025 Annual Meeting: Trial Meets Primary Endpoint of Median Overall Survival and Doubles 1-Year Survival in First-Line Treatment of Metastatic Pancreatic Cancer

Phase 2 (Actuate-1801 Part 3B) trial meets primary endpoint and demonstrates a clinically meaningful increase in median overall survival (10.1…

7 months ago

Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma

Extended Phase 1b trial follow-up on IMA203 PRAME cell therapy in 33 heavily pretreated patients with metastatic melanoma demonstrates favorable…

7 months ago